Published in Blood Weekly, March 2nd, 2006
"The natural history of HBV infection after RT remains unclear. We conducted a systematic review of the published medical literature on the impact of HBsAg seropositivity on survival of RT recipients," wrote F. Fabrizi and colleagues, Maggiore Hospital.
"We used the random effects model of DerSimonian and Laird to generate a summary estimate of the relative risk for mortality and graft loss in HBsAg positive RT recipients across the published studies."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.